Market Research Logo

Septal Occluders - Medical Devices Pipeline Assessment, 2018

Septal Occluders - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Septal Occluders - Medical Devices Pipeline Assessment, 2018 provides an overview of Septal Occluders currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Septal Occluders pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Septal Occluders under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Septal Occluders and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Septal Occluders under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 Septal Occluders Overview
3 Products under Development
3.1 Septal Occluders - Pipeline Products by Stage of Development
3.2 Septal Occluders - Pipeline Products by Segment
3.3 Septal Occluders - Pipeline Products by Territory
3.4 Septal Occluders - Pipeline Products by Regulatory Path
3.5 Septal Occluders - Pipeline Products by Estimated Approval Date
3.6 Septal Occluders - Ongoing Clinical Trials
4 Septal Occluders - Pipeline Products under Development by Companies
4.1 Septal Occluders Companies - Pipeline Products by Stage of Development
4.2 Septal Occluders - Pipeline Products by Stage of Development
5 Septal Occluders Companies and Product Overview
5.1 Aporo Biomedical, Inc. (Inactive) Company Overview
5.1.1 Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.2 CARAG AG Company Overview
5.2.1 CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
5.3 Celyad SA Company Overview
5.3.1 Celyad SA Pipeline Products & Ongoing Clinical Trials Overview
5.4 Cierra, Inc. (Inactive) Company Overview
5.4.1 Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.5 Dextera Surgical Inc Company Overview
5.5.1 Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
5.6 Ension, Inc. Company Overview
5.6.1 Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.7 Lifetech Scientific (Shenzhen) Co Ltd Company Overview
5.7.1 Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.8 Micro Interventional Devices, Inc. Company Overview
5.8.1 Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
5.9 Occlutech International AB Company Overview
5.9.1 Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
5.10 SeptRx, Inc. (Inactive) Company Overview
5.10.1 SeptRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.11 St. Jude Medical LLC Company Overview
5.11.1 St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
5.12 Sutura, Inc. (Inactive) Company Overview
5.12.1 Sutura, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.13 Swissimplant AG (Inactive) Company Overview
5.13.1 Swissimplant AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
5.14 University of Minnesota Company Overview
5.14.1 University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
5.15 Vanderbilt University Company Overview
5.15.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
5.16 Vascular Concepts Ltd Company Overview
5.16.1 Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
5.17 W. L. Gore & Associates Inc Company Overview
5.17.1 W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
6 Septal Occluders- Recent Developments
6.1 May 24, 2018: Real-World Study Results Support Use of Abbott s AMPLATZER Amulet to Reduce Stroke in Patients Suffering from Atrial Fibrillation Without the Need for Lifetime Blood Thinners
6.2 Apr 25, 2018: Xianjian Technology Receives the Most Attention from Institutional Investors
6.3 Apr 24, 2018: Edwards Lifesciences Announces First Quarter 2018 Financial Results
6.4 Apr 20, 2018: Cook Medical Appoints Christina Anne Vice President of Distribution Channel Management
6.5 Apr 03, 2018: FDA Approves GORE CARDIOFORM Septal Occluder for PFO Closure to Prevent Recurrent Ischemic Stroke
6.6 Feb 01, 2018: Edwards Lifesciences Reports Fourth Quarter Results
6.7 Jan 08, 2018: Dongguan Kewei Attends 17th National Thoracic and Cardiovascular Surgery Congress
6.8 Jan 07, 2018: LifeTech Scientific and Ally Bridge Group Form China-Global Medtech Investment and Operating Partnership
6.9 Dec 07, 2017: Edwards Lifesciences Outlines Growth Strategy At Annual Investor Conference
6.10 Nov 09, 2017: Dextera Surgical Reports Fiscal 2018 First Quarter Financial Results
6.11 Oct 24, 2017: LifeTech Helps the Treatment of Patients with a Heart Disease in Linzhi, Tibet
6.12 Oct 24, 2017: Edwards Lifesciences Announces Third Quarter Results
6.13 Oct 13, 2017: LAmbre Overcomes Rare Difficulty and Achieves Perfect Occlusion
6.14 Oct 05, 2017: Dextera Surgical Provides Corporate Update
6.15 Sep 26, 2017: Gore Completes Patient Enrollment in U.S. Pivotal Clinical Study of GORE CARDIOFORM ASD Occluder
6.16 Sep 26, 2017: The LAmbre LAA Closure System is Successfully Implanted at Xijing Hospital in Northwest China for the First Time
6.17 Sep 24, 2017: Edwards Announces Key Events For PCR London Valves 2017
6.18 Sep 19, 2017: Organogenesis Names New Chief Commercial Officer and Chief Operating Officer
6.19 Sep 14, 2017: Landmark Study Published in the New England Journal of Medicine Shows Abbott's AMPLATZER Device Significantly Reduces Risk of Recurrent Stroke for People Living With a Hole in Their Heart
6.20 Aug 30, 2017: Abbott initiates ground-breaking U.S. pivotal study of AMPLATZER device to correct common congenital heart defect in newborns
6.21 Aug 29, 2017: Celyad Reports First Half 2017 Financial Results and Operational Progress
6.22 Aug 08, 2017: Prof. Huang Weijian and His Team Performed Four Challenging LAA Occlusion Procedures Using LAmbre Device
6.23 Aug 08, 2017: Southern Hospital Peng Jian Team Completed the First LAmbre LAA Occluder Implanting in Guangdong
6.24 Aug 08, 2017: Dextera Surgical Reports Fiscal 2017 Fourth Quarter Financial Results
6.25 Jul 30, 2017: The First LAmbre LAA Occluder Training Course Successfully Held by LifeTech
6.26 Jul 26, 2017: Edwards Lifesciences Reports Second Quarter Results
6.27 Jul 24, 2017: The Grand Unveiling of LifeTech's LAmbre Device at CSI 2017
6.28 Jul 24, 2017: LifeTech with LAmbre Appeared On CAFS 2017
6.29 Jul 05, 2017: LAmbre in the Eyes of World-renowned Physicians
6.30 Jul 03, 2017: Lifetech Announced the Launch of its Global Post-market Surveillance Study for Lambre LAA Closure System
7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Septal Occluders - Pipeline Products by Stage of Development
Table 2: Septal Occluders - Pipeline Products by Segment
Table 3: Septal Occluders - Pipeline Products by Territory
Table 4: Septal Occluders - Pipeline Products by Regulatory Path
Table 5: Septal Occluders - Pipeline Products by Estimated Approval Date
Table 6: Septal Occluders - Ongoing Clinical Trials
Table 7: Septal Occluders Companies - Pipeline Products by Stage of Development
Table 8: Septal Occluders - Pipeline Products by Stage of Development
Table 9: Aporo Biomedical, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Patent Foramen Ovale Closure Device - Product Status
Table 11: Patent Foramen Ovale Closure Device - Product Description
Table 12: CARAG AG Pipeline Products & Ongoing Clinical Trials Overview
Table 13: Solysafe Septal Occluder - Degradable Version - Product Status
Table 14: Solysafe Septal Occluder - Degradable Version - Product Description
Table 15: CARAG AG - Ongoing Clinical Trials Overview
Table 16: Solysafe Septal Occluder - Degradable Version - Prospective Single Center Pilot Clinical Study to Evaluate the Safety and Effectiveness of an Intracardiac Septal Closure Device with Biodegradable Framework in Patients with Clinically Significant Atrial Septum Defect (ASD) or Patent Foramen Ovale (PFO)
Table 17: Celyad SA Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Cardiao3 Closure Device - Product Status
Table 19: Cardiao3 Closure Device - Product Description
Table 20: Cierra, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 21: PFx Closure System - Product Status
Table 22: PFx Closure System - Product Description
Table 23: Dextera Surgical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 24: PFO Closure Device - Product Status
Table 25: PFO Closure Device - Product Description
Table 26: Ension, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: Atrial Septal Defect Correction Device - Product Status
Table 28: Atrial Septal Defect Correction Device - Product Description
Table 29: Lifetech Scientific (Shenzhen) Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 30: Absnow Absorbable Occluder - Product Status
Table 31: Absnow Absorbable Occluder - Product Description
Table 32: IrisFIT PFO Occluder - Product Status
Table 33: IrisFIT PFO Occluder - Product Description
Table 34: LAmbre LAA Closure System - Product Status
Table 35: LAmbre LAA Closure System - Product Description
Table 36: Lifetech Scientific (Shenzhen) Co Ltd - Ongoing Clinical Trials Overview
Table 37: LAmbre LAA Closure System - Evaluation of Safety and Efficacy of the New Generation of Left Appendage Closure With the Lambre Device in AF Patients Not Suitable for Use of Warfarin
Table 38: LAmbre LAA Closure System - LifeTech LAmbre Keft Atrial Appendage (LAA) Closure System Post-market Clinical Follow-up
Table 39: LAmbre LAA Closure System - Study of Safety and Efficacy of a Left Atrial Appendage Occulder
Table 40: IrisFIT PFO Occluder - Post Market Clinical Follow-up Study of IrisFIT PFO (Patent Foramen Ovale)
Table 41: Micro Interventional Devices, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 42: Patent Foramen Ovale Fixation Device - Product Status
Table 43: Patent Foramen Ovale Fixation Device - Product Description
Table 44: Occlutech International AB Pipeline Products & Ongoing Clinical Trials Overview
Table 45: Occlutech Figulla Flex UNI - Product Status
Table 46: Occlutech Figulla Flex UNI - Product Description
Table 47: SeptRx, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 48: SeptRx IPO - Product Status
Table 49: SeptRx IPO - Product Description
Table 50: St. Jude Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 51: Amplatzer Amulet Left Atrial Appendage Occluder - Product Status
Table 52: Amplatzer Amulet Left Atrial Appendage Occluder - Product Description
Table 53: AMPLATZER Duct Occluder II AS - Product Status
Table 54: AMPLATZER Duct Occluder II AS - Product Description
Table 55: St. Jude Medical LLC - Ongoing Clinical Trials Overview
Table 56: Amplatzer Amulet Left Atrial Appendage Occluder - AMPLATZER Amulet Left Atrial Appendage Occluder Randomized Controlled Trial
Table 57: Amplatzer Amulet Left Atrial Appendage Occluder - Amplatzer Amulet Observational Post-market Study
Table 58: Amplatzer Amulet Left Atrial Appendage Occluder - Comparison of Amplatzer Amulet vs Watchman Device in Patients Undergoing Left Atrial Appendage Closure: the SWISS-APERO Randomized Clinical Trial
Table 59: Amplatzer Amulet Left Atrial Appendage Occluder - Prevention of Stroke by Left Atrial Appendage Closure in Atrial Fibrillation Patients after Intracerebral Hemorrhage: A Multicenter Randomized Clinical Trial
Table 60: AMPLATZER Duct Occluder II AS - AMPLATZER Duct Occluder II Additional Sizes: ADO II AS Clinical Study
Table 61: Sutura, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 62: HeartStitch - Product Status
Table 63: HeartStitch - Product Description
Table 64: Swissimplant AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Solysafe Septal Occluder - 10Fr Sheath - Product Status
Table 66: Solysafe Septal Occluder - 10Fr Sheath - Product Description
Table 67: University of Minnesota Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Bioresorbable Occlusion Device - Product Status
Table 69: Bioresorbable Occlusion Device - Product Description
Table 70: Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview
Table 71: Self Expanding Ductal Occluder - Product Status
Table 72: Self Expanding Ductal Occluder - Product Description
Table 73: Vascular Concepts Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 74: VSD (Ventricular Septal Device) - Product Status
Table 75: VSD (Ventricular Septal Device) - Product Description
Table 76: W. L. Gore & Associates Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 77: BioTREK - Product Status
Table 78: BioTREK - Product Description
Table 79: GORE HELEX Septal Occluder - PFO - Product Status
Table 80: GORE HELEX Septal Occluder - PFO - Product Description
Table 81: W. L. Gore & Associates Inc - Ongoing Clinical Trials Overview
Table 82: GORE HELEX Septal Occluder - PFO - GORE HELEX Septal Occluder / GORE CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-confirmed TIA in Patients with Patent Foramen Ovale (PFO)
Table 83: Glossary
1.2 List of Figures
Figure 1: Septal Occluders - Pipeline Products by Stage of Development
Figure 2: Septal Occluders - Pipeline Products by Segment
Figure 3: Septal Occluders - Pipeline Products by Territory
Figure 4: Septal Occluders - Pipeline Products by Regulatory Path
Figure 5: Septal Occluders - Pipeline Products by Estimated Approval Date
Figure 6: Septal Occluders - Ongoing Clinical Trials

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report